Preparation method of carboxymethylated curdlan composite hydrogel capable of promoting healing of infectious skin wounds
The composite hydrogel designed by the coordination effect of the gel and copper-zinc ion can be obtained through carboxymethylation, which achieves the early rapid release of Cu2+ and the late slow release of Zn2+, solving the problem of infectious skin wound healing and demonstrating excellent tissue stickiness Adhesion and antibacterial properties promote wound healing and tissue regeneration.
Patent Information
- Application Number
- CN202410929070.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-11
- Publication Date
- 2024-11-15
- Estimated Expiration
- 2044-07-11
AI Technical Summary
The prior art is difficult to effectively solve the problem of healing of infectious skin wounds, especially due to the accumulation of antibiotic-resistant biofilms formed by bacteria and their metabolites in the extracellular matrix, resulting in delayed wound healing or transition to chronic difficult healing.
The composite hydrogel designed with the coordination effect of carboxymethylation of the gel and copper-zinc ion can be achieved. The infection is removed through early rapid release of Cu2+, and the Zn2+ later promotes wound healing and tissue regeneration, realizing time-sharing ion delivery.
The hydrogel exhibits excellent tissue adhesion, injectability and antibacterial properties, can quickly repair infectious wounds, promote wound healing, and provide a suitable microenvironment during tissue regeneration, with broad application prospects.
Smart Images

Figure CN118955945A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedicine, and particularly relates to a method for preparing a carboxymethylated curdlan composite hydrogel capable of promoting healing of infectious skin wounds. Background Art
[0002] Infected wounds caused by large-area trauma or surgery are an important clinical problem. The weak defense barrier of the wound and the plasma nutrients exposed to the air make it very easy for pathogenic microorganisms to adhere, aggregate and grow on the wound surface, resulting in delayed wound healing and even possible infectious complications. In addition, the accumulated bacteria and their metabolites are also embedded in the extracellular matrix to form a biofilm that is difficult to eliminate and has antibiotic resistance. Explosive bacterial infections can turn acute infections into chronic infections, forming chronic, difficult-to-heal wounds. Therefore, it is crucial to develop multifunctional wound dressings that can eliminate infections in a timely manner in the early stages and promote wound healing and tissue regeneration in the middle and late stages.
[0003] Curdlan is a linear glucan composed of β-1,3-D glycosidic bonds. However, due to its water insolubility and lack of antibacterial activity, curdlan itself is difficult to deal with infection problems in wound repair.
[0004] Inorganic active ions are important components of some transcription factors, enzymes and proteins, and affect a series of cellular activities during the wound healing process. However, a single ion cannot meet the diverse needs of the wound healing process. In addition, the unstable release of ions may be toxic to tissues. Therefore, it is very necessary to effectively regulate the release behavior of active ions to achieve time-sharing delivery to meet the different needs of the wound healing stage. Summary of the invention
[0005] The technical problem to be solved by the present invention is to provide a method for preparing a carboxymethylated curdlan composite hydrogel that can promote the healing of infected skin wounds, and in particular, to provide a method for preparing a carboxymethylated curdlan hydrogel with a "fast and slow release of copper and zinc ions" and its application. 2+ 、Zn 2+ A novel polyol based on carboxymethylated curdlan and Ca 2+ As a substrate, Cu can be delivered in time 2+ 、Zn 2+ The composite hydrogel realizes Cu 2+ Early and rapid clearance of infection, Zn 2+ The later stage promotes the therapeutic effect of wound healing and tissue regeneration.
[0006] A method for preparing a carboxymethylated curdlan hydrogel of the present invention comprises:
[0007] (1) Preparation of carboxymethylated curdlan:
[0008] The curdlan gum and isopropanol are mixed, and then a sodium hydroxide solution is added and stirred, and then a chloroacetic acid solution is added to react, and after the reaction is completed, the carboxymethylated curdlan gum sample is obtained by suction filtration, washing, dialyzing, and freeze-drying;
[0009] (2) Preparation of carboxymethylated curdlan hydrogel:
[0010] Carboxymethylated curdlan and water are mixed to obtain a carboxymethylated curdlan aqueous solution, and then an active ion solution is added and stirred to obtain a carboxymethylated curdlan hydrogel.
[0011] Preferably, in step (1), the curdlan and isopropanol are mixed, and then a sodium hydroxide solution is added and stirred to mix, and then heated in an oil bath, and then a chloroacetic acid solution is added. After the reaction is completed, the carboxymethylated curdlan is obtained by suction filtration, washing, dialyzing, and freeze-drying.
[0012] Preferably, in step (1), the mass volume ratio of curdlan to isopropanol is 2-5wt.%; the degree of substitution of the carboxymethylated curdlan is 0.3-0.5. When the degree of substitution is less than 0.3, the curdlan cannot be well dissolved in water; when the degree of substitution is greater than 0.5, the curdlan cannot form a hydrogel with inorganic active ions.
[0013] Preferably, the sodium hydroxide solution is added in step (1) by slowly dropping the sodium hydroxide solution into the reaction system in 5-10 portions, each time with an interval of 5-10 minutes, and stirring at a constant speed for 1-2 hours at room temperature.
[0014] The concentration of sodium hydroxide in step (1) is 25-35 wt.%.
[0015] Preferably, in step (1), oil bath heating is performed at 50-60° C., and the chloroacetic acid solution is added dropwise to the reaction system in 5-10 times, each time with an interval of 5-10 minutes, and the reaction system is stirred at a constant temperature and uniform speed for 2-5 hours.
[0016] Preferably, the ratio of the curdlan, sodium hydroxide solution and chloroacetic acid solution is 1-5 g: 8-12 mL: 8-12 mL;
[0017] Furthermore, the ratio of the curdlan, sodium hydroxide solution and chloroacetic acid solution is 3 g: 10 mL: 10 mL;
[0018] The sodium hydroxide concentration is 25-35wt.%, and preferably the sodium hydroxide concentration is 30wt.%.
[0019] The chloroacetic acid solution is an isopropanol solution of chloroacetic acid, wherein the concentration of the isopropanol solution of chloroacetic acid is 30-40% g / mL, preferably 36%.
[0020] Preferably, the reaction in step (1) is carried out in an oil bath at 50-60° C. for 2-5 hours.
[0021] Preferably, the concentration of the aqueous solution of carboxymethylated curdlan in step (2) is 8-15 wt.%; and the concentration of the active ion solution is 0.1-1 mol / L.
[0022] Furthermore, in the step (2), the concentration of the aqueous solution of carboxymethylated curdlan is 10-15 wt. %; and the concentration of the active ion solution is 1 mol / L.
[0023] The active ion solution is an active ion aqueous solution.
[0024] Preferably, the active ion mixture in step (2) is calcium ions and copper ions, calcium ions and zinc ions, or calcium ions, zinc ions and copper ions.
[0025] The calcium ion source includes calcium chloride; the copper ion source includes at least one of copper chloride and copper sulfate; and the zinc ion source includes zinc chloride.
[0026] Preferably, in the final carboxymethylated curdlan hydrogel in step (2), the molar ratio of calcium ions to copper ions, or calcium ions to zinc ions, or calcium ions to copper and zinc ions is 8:1-18:1.
[0027] Further preferably, the molar ratio of calcium ions, copper ions and zinc ions in the active ions is 18:1:1.
[0028] Preferably, in step (2), the volume ratio of the carboxymethylated curdlan aqueous solution to the active ion aqueous solution is 2:1-8:1.
[0029] Further preferably, in step (2), the volume ratio of the carboxymethylated curdlan aqueous solution to the active ion aqueous solution is 5:1.
[0030] Preferably, the stirring time in step (2) is 2-5 min.
[0031] The invention provides a carboxymethylated curdlan hydrogel prepared by the method.
[0032] The present invention provides an application of the carboxymethylated curdlan hydrogel in preparing skin wound healing dressings, wound tissue repair and regeneration dressings, such as a dressing for promoting healing of infectious skin wounds, such as injecting the hydrogel into the wound surface for wound tissue repair.
[0033] The present invention provides a novel injectable, self-healing, and rapidly releasing Cu 2+ , slowly releases Zn 2+ CRc-Cu-Zn composite hydrogel and its application in rapid repair of bacterial infected wounds.
[0034] The method firstly modifies the curdlan by carboxylmethylation through a solvent method, and then adds an active ion solution to prepare a CRc composite hydrogel through ion coordination cross-linking.
[0035] The hydrogel exhibits excellent tissue adhesion, injectability, rapid self-healing and broad-spectrum antibacterial properties. Animal experiments have proven that the hydrogel can promote the rapid repair of infected wounds. Combined with the above characteristics, this new type of injectable, self-healing, multifunctional hydrogel with good antibacterial activity is expected to be used as a new type of wound dressing in the rapid repair of chronic wounds such as infected wounds, as well as anti-infective tissue engineering implant materials.
[0036] Beneficial Effects
[0037] (1) The carboxymethylated curdlan hydrogel prepared by the present invention is an unbranched β-1,3 glucan;
[0038] (2) The carboxymethylated curdlan hydrogel prepared by the present invention is safe and simple, has injectability and self-healing properties, has strong adhesion to skin tissue, can be used as a wound dressing to fill irregular deep wounds, and can effectively coordinate the advantages of various components to provide a suitable microenvironment for tissue growth and function;
[0039] (3) The carboxymethylated curdlan hydrogel prepared by the present invention can realize the time-sharing delivery of active ions, wherein Cu 2+ In the early rapid release, Zn 2+ The drug is slowly and continuously released, thus achieving the effect of anti-infection in the early stage and promoting tissue repair in the later stage;
[0040] (4) The present invention is suitable for dressings for acute / chronic wounds in different environments and tissue regeneration materials, and has broad application prospects.
[0041] (5) The present invention combines a certain concentration of carboxymethylated curdlan with an appropriate proportion of active ions (Ca 2+ , Cu 2+ 、Zn 2 +) solution, and carboxymethylated curdlan hydrogel was prepared by ionic crosslinking method. The prepared hydrogel has rapid gelation, good injectability, self-healing property, tissue adhesion property and excellent antibacterial effect, and can effectively promote the repair and regeneration of skin tissue defects, and has potential application prospects in the treatment of wound infection. BRIEF DESCRIPTION OF THE DRAWINGS
[0042] Figure 1 The rheological behavior diagram of the hydrogel prepared in Example 4; wherein A: the viscosity variation curve of the CRc-Cu-Zn hydrogel with shear rate, B: the variation curve of the storage modulus G′ and the loss modulus G″ of the CRc-Cu-Zn hydrogel in the strain sweep test, C: the variation curve of the storage modulus G′ and the loss modulus G″ under 1-700% alternating step strain cycle;
[0043] Figure 2 Quantitative graph of tissue adhesion strength of the hydrogels prepared in Examples 1-4;
[0044] Figure 3 Graphs showing ion release of the hydrogels prepared in Examples 1-4; wherein A: cumulative ion release of CRc-Cu hydrogel at different time points in PBS buffer; B: cumulative ion release of CRc-Zn hydrogel at different time points in PBS buffer; C: cumulative ion release of CRc-Cu-Zn hydrogel at different time points in PBS buffer;
[0045] Figure 4 This is a photo of the colonies after the hydrogel prepared in Example 1-4 was co-cultured with Escherichia coli and Staphylococcus aureus for 24 hours;
[0046] Figure 5 The proliferation status of L929 cells in the hydrogels prepared in Examples 1-4;
[0047] Figure 6 This is a quantitative analysis of the wound healing area in Example 3 and Example 4 during injury repair in SD rats. DETAILED DESCRIPTION
[0048] The present invention will be further described below in conjunction with specific embodiments. It should be understood that these embodiments are only used to illustrate the present invention and are not intended to limit the scope of the present invention. In addition, it should be understood that after reading the content taught by the present invention, those skilled in the art can make various changes or modifications to the present invention, and these equivalent forms fall within the scope limited by the appended claims of the application equally.
[0049] Example 1
[0050] The invention discloses a carboxymethylated curdlan hydrogel capable of promoting the healing of infected skin wounds. The hydrogel comprises the following raw materials: carboxymethylated curdlan and active ions.
[0051] In this embodiment, the active ion is calcium chloride.
[0052] A method for preparing a carboxymethylated curdlan hydrogel capable of promoting healing of infected skin wounds comprises the following steps:
[0053] (1) Preparation of carboxymethylated curdlan: 3 g of curdlan was mixed with 80 mL of isopropanol and stirred at room temperature for 1 h to make it uniformly dispersed. 10 mL of 30 wt.% sodium hydroxide solution was slowly dripped into the reaction system in 10 times, with an interval of 10 min each time, and stirred at room temperature for 1.5 h. The reaction system was then heated to 55°C, 3.6 g of chloroacetic acid was dissolved in 10 mL of isopropanol and dripped into the reaction system in 10 times, with an interval of 10 min each time. After the reaction system was stirred at a constant temperature and at a constant speed for 4 h, the reaction was stopped and the crude product was obtained by suction filtration. After washing the crude product with anhydrous ethanol and acetone, it was dissolved in water, dialyzed by 3D and freeze-dried to obtain a carboxymethylated curdlan with a degree of substitution of 0.37.
[0054] (2) The carboxymethylated curdlan obtained in 1) was dissolved in water to prepare a 15 wt.% carboxymethylated curdlan solution. 400 μL of 1 mol / L calcium chloride solution was slowly added dropwise to 2 mL of the carboxymethylated curdlan solution and stirred at room temperature to obtain a hydrogel CRc.
[0055] Example 2
[0056] The preparation method of carboxymethylated curdlan hydrogel (CRc-Cu) in this embodiment is different from that in Example 1 in that 360 μL 1 mol / L calcium chloride and 40 μL 1 mol / L copper chloride are mixed to prepare the active ion solution, and the rest is the same as in Example 1.
[0057] Example 3
[0058] The preparation method of the carboxymethylated curdlan hydrogel (CRc-Zn) of this embodiment is different from that of Example 1 in that 360 μL 1 mol / L calcium chloride and 40 μL 1 mol / L zinc chloride are mixed to prepare the active ion solution, and the rest is the same as that of Example 1.
[0059] Example 4
[0060] The preparation method of the carboxymethylated curdlan hydrogel (CRc-Cu-Zn) of this embodiment is different from that of Example 1 in that: 360 μL 1 mol / L calcium chloride, 20 μL 1 mol / L copper chloride, and 20 μL zinc chloride are mixed to prepare the active ion solution, and the rest is the same as that of Example 1.
[0061] The final carboxymethylated curdlan hydrogel was subjected to performance tests, as follows:
[0062] Test 1: The injectability and self-healing properties of the hydrogel (CRc-Cu-Zn) prepared in Example 4 were tested, specifically: (1) Macroscopic injectability: The hydrogel was added to a syringe and then injected onto a flat plate.
[0063] (2) Micro-injectability: The test was conducted using a rheometer (RS150L, Haake Rheometer, Germany). 0.5 mL of hydrogel was added to the vertebral plate, and the rotor-vertebral plate spacing was 1.0 mm to ensure contact between the rotor and the hydrogel. The viscosity change at different shear rates was tested, with a shear rate range of 0.01-1000 s -1 .
[0064] (3) Microscopic self-healing properties: First, 0.5 mL of hydrogel was added to the vertebral lamina and the shear strain was 0-10 3 %, shear frequency is 1rad·s -1 The experiment was conducted in strain scanning mode to obtain the critical strain point of the hydrogel. Then the self-healing behavior of the hydrogel was tested using oscillation mode-time scanning. The amplitude oscillation strain was switched from 1% (3 cycles, each cycle time was 50s) to 700% (2 cycles, each cycle time was 50s). The strains of 1% and 700% were alternated.
[0065] like Figure 1 As shown in A, the hydrogel prepared in Example 4 is injected onto a flat plate using a syringe to form the word "DHU", indicating that the hydrogel has good injectability and can be injected into the wound in situ.
[0066] like Figure 1 As shown in B, the shear strain gradually increases, and the G' and G" of the CRc-Cu-Zn hydrogel gradually decrease, and the curve of G' and the curve of G" intersect at a strain of 643.7%. The intersection of G' and G" indicates the collapse of the internal structure of the hydrogel, indicating that the hydrogel transforms from a solid with gel properties to a liquid-like with fluid properties. The larger the critical strain, the greater the deformation that the hydrogel can withstand to resist shear stress. Compared with the self-healing hydrogels in previous literature, the CRc-Cu-Zn hydrogel has a higher critical strain, which indicates that the CRc-Cu-Zn hydrogel can withstand greater strain.
[0067] The strains of 700% and 1% were selected to scan the hydrogel time. Figure 1 It can be seen from Figure 3 that after alternating strains of 1% and 700%, when the strain is restored from 700% to 1%, the G' and G" values of the CRc-Cu-Zn hydrogel almost return to their original values, indicating that CRc-Cu-Zn has rebuilt its own structure and has basically achieved self-healing even with partial loss.
[0068] Test 2: Tissue adhesion test was performed on the hydrogels (CRc, CRc-Cu, CRc-Zn, CRc-Cu-Zn) prepared in Examples 1-4, specifically:
[0069] Step 1: Take fresh pig skin, dehair, defat and disinfect it, then cut it into 30mm×10mm×1mm size and wash it in PBS for 20 minutes.
[0070] Step 2: Inject the newly prepared hydrogel (10mm×10mm×1mm) onto the pig skin and overlap it with another piece of pig skin of the same size. After curing for 30 minutes, perform the overlap shear test at a tensile speed of 5mm / min using a computerized tensile (compression) force testing machine (HY-940FS). All groups were tested 3 times to obtain the average adhesion strength;
[0071] The average adhesion strength of the hydrogel is Figure 2 As shown in the figure, it can be seen that all CRc hydrogels have a certain adhesion strength to pig skin, among which CRc-Cu-Zn hydrogel shows the highest adhesion strength (24.50±3.503kPa). This shows that when CRc hydrogel is used as a wound dressing, it is beneficial to adhere to the wound surface, close the wound, and provide protection for wound healing.
[0072] Test 3: The hydrogels (CRc, CRc-Cu, CRc-Zn, CRc-Cu-Zn) prepared in Examples 1-4 were subjected to ion release tests, specifically:
[0073] Step 1: Soak 600 μL of hydrogel sample in 10 mL of PBS;
[0074] Step 2: Collect supernatant at preset time points (1 day, 2 days, 4 days, 6 days) for ICP test
[0075] exist Figure 3 The release of Cu from CRc-Cu, CRc-Zn, and CRc-Cu-Zn hydrogels in PBS was studied. 2+ and Zn 2+ The amount of Figure 3 As shown, it can be observed that CRc-Cu hydrogel only releases Cu 2+Similarly, CRc-Zn hydrogels only released Zn 2+ , and the release rate gradually decreases with time. CRc-Cu-Zn hydrogel can release Cu 2+ and Zn 2+ , Cu 2+ The concentration of Zn 2+ .
[0076] Test 4: The hydrogels (CRc, CRc-Cu, CRc-Zn, CRc-Cu-Zn) prepared in Examples 1-4 were subjected to in vitro antibacterial tests, specifically:
[0077] Step 1: 600 μL of different hydrogel samples were sterilized by UV light for 4 h and then placed in a 24-well plate;
[0078] Step 2: Add 100 μL of bacterial suspension (10 5 CFU / mL), and cultured in a 37°C incubator for 24 h;
[0079] Step 3: Use PBS to increase the concentration of the bacterial suspension co-cultured with the material in step 2 to 10 2 CFU / mL. Pipette 100 μL of diluted bacterial solution onto solid culture medium, use a sterile spreading stick to evenly spread the bacterial solution over the entire plate, place in a 37°C incubator for 24 hours, then take photos and count the number of colonies;
[0080] like Figure 4 As shown in the figure, compared with the control group, the CRc material had no antibacterial properties against Escherichia coli and Staphylococcus aureus, and showed a trend of bacterial growth; CRc-Zn hydrogel had no antibacterial properties against Escherichia coli and Staphylococcus aureus, and showed a trend of bacterial growth; 2+ The release amount in 24 hours (0.96ppm) is less than that of Zn 2+ The effective antibacterial concentration (6.5ppm) of CRc-Cu and CRc-Cu-Zn hydrogels was not able to effectively inhibit the growth of bacteria. Escherichia coli and Staphylococcus aureus were almost not seen in the plates of CRc-Cu and CRc-Cu-Zn hydrogels, indicating that the presence of Cu 2+ The CRc hydrogel has excellent antibacterial properties, which can resist bacterial infection at the wound site and accelerate the wound healing process.
[0081] Test 5: The hydrogels (CRc, CRc-Cu, CRc-Zn, CRc-Cu-Zn) prepared in Examples 1-4 were tested for fibroblast activity and proliferation ability. Specifically:
[0082] Step 1: sterilize the material with UV light for 2.0 h each, prepare the extract, and then filter it with a 0.22 μm microporous filter combined with a 10 mL syringe;
[0083] Step 2: Follow the 5×10 3 The number of live cells / well was calculated by inoculating the revived cells into the well plate. The blank group was treated with complete culture medium, and the experimental group was treated with the corresponding extract. Each group had three parallels, and the corresponding culture medium was replaced every day.
[0084] Step 3: Use CCK-8 method to measure cell proliferation at preset time points of 24h, 48h, and 72h. Figure 5 As shown, the results indicate that all CRc hydrogels have a promoting effect on the growth of fibroblasts and can be used in clinical practice.
[0085] Test 6: The healing effect of the hydrogels (CRc-Cu, CRc-Cu-Zn) prepared in Examples 2 and 4 on the infected wound was evaluated, specifically:
[0086] Step 1: Select male SD rats (160-200g) for animal experiments. First, inject Staphylococcus aureus intraperitoneally for anesthesia. After the rat skin is disinfected, use a scalpel to create three full-thickness circular wounds with a diameter of 1 cm on the back of the rat, and stick a 1 cm rubber ring on the wound. Use a sterile syringe to drip 20 μL (10 7 CFU / mL) and fixed with 3M film to prevent bacterial liquid from leaking out.
[0087] Step 2: 24 h after infection, the wounds were treated with PBS, CRc-Cu and CRc-Cu-Zn, respectively. Wound photos were taken on days 5, 7 and 10 of treatment, and the wound area was calculated using ImageJ. The wound closure rate was calculated according to the following formula:
[0088] Wound closure rate = (initial wound area - current wound area) / initial wound area × 100%
[0089] The percentage of wound healing is as follows Figure 6 As shown in the results, on the 10th day, the CRc-Cu group was able to basically close the wound, with a wound closure rate of 92.40±0.81%, and the CRc-Cu-Zn group was able to completely close the wound, with a wound closure rate of 99.01±1.18%, both higher than the PBS group (79.07±1.02%). This indicates that during the wound recovery period, the CRc-Cu-Zn hydrogel dressing has a significant advantage in promoting the healing of infected wounds.
Claims
1. A method for preparing a carboxymethylated curdlan hydrogel, include: (1) mixing curdlan and isopropanol, adding sodium hydroxide solution and stirring, then adding chloroacetic acid solution, reacting, and after the reaction is completed, filtering, washing, dialyzing, and freeze-drying to obtain carboxymethylated curdlan; (2) dissolving carboxymethylated curdlan in water to obtain an aqueous solution of carboxymethylated curdlan, then adding an active ion mixed solution and stirring to obtain a carboxymethylated curdlan hydrogel.
2. The preparation method according to claim 1, It is characterized in that In the step (1), the mass volume ratio of the curdlan to isopropanol is 2-5wt.%; and the degree of substitution of the carboxymethylated curdlan is 0.3-0.
5.
3. The preparation method according to claim 1, It is characterized in that The reaction in step (1) is carried out in an oil bath at 50-60° C. for 2-5 hours.
4. The preparation method according to claim 1, It is characterized in that The concentration of the aqueous solution of carboxymethylated curdlan in step (2) is 8-15 wt. %; the concentration of the active ion solution is 1.0-0.3 mol / L.
5. The preparation method according to claim 1, It is characterized in that The active ion mixture in step (2) is: calcium ions and copper ions, calcium ions and zinc ions, or calcium ions, zinc ions and copper ions; The calcium ion source includes calcium chloride; the copper ion source includes at least one of copper chloride and copper sulfate; and the zinc ion source includes zinc chloride.
6. The preparation method according to claim 5, It is characterized in that In the step (2), the molar ratios of calcium ions to copper ions, calcium ions to zinc ions, and calcium ions to copper and zinc ions in the final carboxymethylated curdlan hydrogel are 8:1-18:
1.
7. The preparation method according to claim 1, It is characterized in that The volume ratio of the carboxymethylated curdlan aqueous solution to the active ion aqueous solution in step (2) is 2:1-8:
1.
8. The preparation method according to claim 1, It is characterized in that The stirring time in step (2) is 2-5 min.
9. Use of the carboxymethylated curdlan hydrogel according to claim 1 in the preparation of skin wound healing dressings, traumatic tissue repair and regeneration dressings.
Citation Information
Patent Citations
Carboxymethyl curdlan aqueous solution or hydrogel, preparation method and application thereof
CN106188574A
Ionic-crosslinked carboxymethyl curdlan physical hydrogel and preparation method thereof
CN110041537A
